Validation of the multidimensional impact of Cancer Risk Assessment Questionnaire to assess impact of waiting for genome sequencing results.
Megan C BestChristine E NapierTimothy E SchlubNicole BartleyBarbara B BieseckerMandy L BallingerPhyllis N ButowPublished in: Psycho-oncology (2022)
The adapted MICRA identified test-related anxiety and uncertainty in a population of cancer patients waiting for germline GS results. Results suggest that the distress and uncertainty sub-scales of the adapted measure are most useful in this context.